Here are five things to know:
1. Presently, the firm has a “buy” rating on AmSurg shares.
2. The analysts’ updated price target indicates a 20.68 percent potential upside from AmSurg’s current price.
3. Last Wednesday, AmSurg shares hit $74.58, down 1.92 percent.
4. AmSurg has a 50-day moving average of $76.93 and 200-day moving average of $74.82.
5. The market cap is $4.01 billion.
More articles on surgery centers:
St. Elizabeth Healthcare to testify against Christ Hospital’s $24M ASC: 7 key points
BCBS of Texas requests 60% price hike: 5 takeaways
Will IRS’ latest ruling compromise ACOs’ sustainability? 4 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
